Literature DB >> 1446850

Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients.

J M Castrillo1, C Montalban, G Obeso, M A Piris, M C Rivas.   

Abstract

Clinico-pathological features of 56 patients with primary gastric lymphoma were evaluated retrospectively. All cases were regraded according to a classification of Isaacson et al into high grade and low grade B-cell mucosa associated lymphoid tissue lymphoma. A third group of mixed grade was recognised in 11 patients with low grade who also had occasional areas of high grade. Low grade and mixed grade patients had a 100% actuarial survival at 156 months, which was significantly better (p < 0.01) than that of 52% for patients with high grade disease. Different treatment methods--surgery, chemotherapy, or a combination of both--did not significantly affect survival. Low grade tumours occurred mainly in men with a history of several years, and who presented with non-specific gastric symptoms without remarkable exploratory or laboratory findings: most patients were in stage IE-IIE and achieved remission and cure. High grade can have a shorter history, systemic symptoms, abnormal exploratory and laboratory findings, gastric tumour masses, stage IV disease, and a worse outcome. The only significant prognostic factors for survival were the type of lymphoma and stage IV disease. These findings support the Isaacson classification system which separates two extreme groups of gastric lymphomas with different morphology, behaviour, and outcome. The presence of limited areas of high grade in a specimen showing low grade does not change the outcome but suggests that primary gastric lymphoma forms a continuum between these extreme types.

Entities:  

Mesh:

Year:  1992        PMID: 1446850      PMCID: PMC1379594          DOI: 10.1136/gut.33.10.1307

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Monoclonal small (well-differentiated) lymphocytic proliferations of the gastrointestinal tract resembling lymphoid hyperplasia: a neoplasm of uncertain malignant potential.

Authors:  J S Burke; K Sheibani; B N Nathwani; C D Winberg; H Rappaport
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

2.  Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach.

Authors:  J M Burgers; B G Taal; P van Heerde; R Somers; F C den Hartog Jager; A A Hart
Journal:  Radiother Oncol       Date:  1988-04       Impact factor: 6.280

3.  Classifying primary gut lymphomas.

Authors:  P G Isaacson; J Spencer; D H Wright
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

4.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

5.  Primary gastric lymphoma.

Authors:  M S Hockey; J Powell; J Crocker; J W Fielding
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

6.  Is an aggressive surgical approach to the patient with gastric lymphoma warranted?

Authors:  C B Rosen; J A van Heerden; J K Martin; L E Wold; D M Ilstrup
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

7.  Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.

Authors:  P Isaacson; D H Wright
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

8.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

9.  Gastric lymphoma: a clinical study of 28 cases and an evaluation of prognostic factors.

Authors:  J Barzilay; E Rakowsky
Journal:  Clin Oncol       Date:  1984-09

10.  Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases.

Authors:  B Dragosics; P Bauer; T Radaszkiewicz
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

View more
  3 in total

1.  Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.

Authors:  Agustín Avilés; Natividad Neri; M Jesús Nambo; Judith Huerta-Guzman; Sergio Cleto
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma.

Authors:  Y Kodera; Y Yamamura; S Nakamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

3.  Primary gastric lymphoma in clinical practice 1973-1992.

Authors:  A F Muller; A Maloney; D Jenkins; F Dowling; P Smith; E M Bessell; P J Toghill
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.